Zotefoams trading update: 26% revenue growth points to a strong start in 2026
Zotefoams has opened 2026 with a genuinely encouraging trading update. Revenue for the four months to 30 April 2026 rose 26% year-on-year to £64.1 million, helped by strong demand across key markets and a contribution from Overseas Konstellation Company, or OKC.
For retail investors, the big takeaway is simple: this was not a wobbly update dressed up to look better than it is. The Board said full-year expectations are unchanged, margins are in line with expectations, cash generation has been robust, and the balance sheet remains strong. That is the kind of combination the market usually likes.
Key numbers from the Zotefoams RNS investors should know
| Metric | Figure | Comment |
|---|---|---|
| Group revenue | £64.1 million | Up 26% year-on-year in the four months to 30 April 2026 |
| EMEA revenue | £50.1 million | Up 24%, including a £9.8 million contribution from OKC |
| North America revenue | £12.1 million | Up 30% organically |
| Asia revenue | £1.9 million | Roughly double the prior year period |
| Market expectations for FY 2026 revenue | £190.8 million | Board said expectations remain unchanged |
| Market expectations for FY 2026 adjusted profit before tax | £26.3 million | Also unchanged following this statement |
Why this Zotefoams revenue growth looks better than just an acquisition boost
It would be easy to look at the 26% revenue increase and assume this is mainly an acquisition story because OKC added £9.8 million in EMEA. That definitely matters, but it is not the whole picture.
North America grew 30% organically. Organic growth means growth excluding acquisitions, so that is the cleanest signal that demand is improving in the core business. Asia also roughly doubled revenue, albeit from a small base, which adds to the sense that this is a broader operational improvement rather than a one-off accounting lift.
EMEA: good performance, but the detail matters
EMEA revenue rose 24% to £50.1 million, driven by the £9.8 million contribution from OKC. Strip that out, and the underlying EMEA business was described as stable against a strong comparator of £40.4 million in the prior year period.
That comparator matters because last year benefited from exceptionally high Footwear volumes. In plain English, the bar was high, so “stable” is not a bad result at all. It suggests weakness in Footwear was expected and already factored into management’s thinking.
North America: arguably the standout in this update
North America delivered revenue of £12.1 million, up 30% organically year-on-year. Management put that down to recently expanded capacity from its second low-pressure vessel and demand in Consumer & Lifestyle and Transport & Smart Technologies.
That is encouraging for two reasons. First, extra capacity is now translating into sales. Second, growth is coming through in more than one end market, which usually makes revenue quality look stronger.
Asia: small today, but clearly part of the growth plan
Asia revenue reached £1.9 million, roughly double the prior year period. The absolute number is still modest, so nobody should pretend Asia is moving the whole Group today.
Even so, the strategic angle is important. Zotefoams is investing in Vietnam and South Korea, with operations expected to begin towards the end of the year. That points to management building capacity where future customer demand is expected, especially around Footwear innovation and regional expansion.
Footwear moderation is the main weak spot, but it does not look alarming
The soft patch in this update is Footwear, which sits inside the Consumer & Lifestyle vertical and is the largest component of that area. Revenues there moderated, but crucially this was described as expected.
That wording matters. Investors usually get nervous when a company starts talking about slowing demand, but this does not read like a profit warning in disguise. Management is saying other target markets, plus OKC, should more than offset the weaker Footwear trend for the full year.
My view is that this is a manageable negative rather than a red flag. If Footwear weakens more sharply later in the year, that could become a bigger issue, but based on this RNS alone the business looks diversified enough to absorb it.
Margins, cash generation and OKC integration add quality to the update
Revenue growth gets the headlines, but the more reassuring lines in this statement are about margins and cash. Zotefoams said margins in the period were in line with expectations and cash generation was robust, helped by working capital efficiency.
That is important because fast-growing revenue is less impressive if profitability slips or cash gets tied up in stock and debtors. We do not get the exact margin, profit or cash figures here – they were not disclosed – but the tone is clearly steady rather than stretched.
On top of that, OKC integration is said to be in line with plan. That reduces one of the obvious investor concerns whenever a business adds acquired revenue. If integration starts to wobble, synergies can disappear quickly. There is no sign of that here.
Zotefoams strategy update: Vietnam, South Korea, AI and partner rollout
This RNS was not just about near-term trading. Zotefoams also flagged progress on major projects in Vietnam, South Korea and the UK, alongside the launch of its Global Approved Partners programme.
The company also said it is advancing the use of AI to drive productivity and innovation. That sounds promising, although the financial impact is not disclosed, so investors should treat it as strategic intent rather than a number you can plug into forecasts today.
The bigger point is that management appears to be investing while trading is strong, not because trading is weak. That is usually a healthier position to be in.
2026 outlook unchanged supports confidence in full-year forecasts
The Board said full-year expectations remain unchanged, despite elevated macroeconomic uncertainty. It also specifically noted current market expectations before this statement were for revenue of £190.8 million and adjusted profit before tax of £26.3 million.
That matters because unchanged guidance after a strong opening period suggests management sees current performance as sustainable enough to back those numbers. It also suggests no nasty cost surprise has appeared in the background.
There are still risks. The company is monitoring instability in the Middle East and has taken steps to mitigate raw material and other cost movements. That tells you management is not ignoring the wider environment, which is sensible, but those external factors remain worth watching.
What this Zotefoams AGM trading update means for retail investors
Overall, this looks like a positive update. Revenue growth was strong, North America impressed, Asia is moving in the right direction, margins held up, cash generation was robust, and guidance stayed intact.
The main caution is that not every part of the business is flying. Footwear is cooling, and the macro backdrop is still uncertain. But right now, Zotefoams appears to be handling that mix well, with enough diversification and operational control to keep the story on track.
If I were a retail investor reading this fresh, I would come away thinking the investment case has been reinforced rather than changed. The company is growing, integrating OKC without obvious drama, expanding capacity in sensible places, and not chasing growth at the expense of profitability. That is a pretty good place to be in late May.
